Huma

Huma is a global healthcare AI company founded in 2011 with a slogan to accelerate the adoption of digital solutions in care and research. The company has made significant strides, with its technology empowering over 3,000 hospitals and clinics, featuring 500+ unique deployments across 70+ countries. Notably, Huma's software has engaged and screened over 35 million individuals, with 1.8 million active users. Renowned for its involvement in major national healthcare projects globally, Huma has garnered attention for its work with large pharma companies and CROs, and its last investment of $80.00M in Series D came on 16 July 2024 from HAT Technology & Innovation Fund, Hitachi Ventures, Leaps by Bayer, AstraZeneca. The company's Cloud Platform, backed by FDA 510(k) Class II, EU\/MDR Class IIb, and Saudi FDA Class C regulatory clearance, offers robust infrastructure for launching digital solutions in healthcare and research, with a focus on disease-agnostic flagship products and the ability to host AI\/ML models. Huma operates from its headquarters in the United Kingdom and operates within the AI, Digital Health, Health Care, and SaaS industries.